|
Delayed
NSE India S.E.
03:31:12 16/01/2026 pm IST
|
5-day change
|
1st Jan Change
|
|
1,351.00 INR
|
-0.01%
|
 |
+2.33%
|
+0.40%
|
|
24/12 |
Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026
|
CI
| |
18/12 |
Concord Biotech Names CFO
|
MT
| |
18/12 |
Concord Biotech appoints Raviraj Karia as CFO
|
RE
| |
18/12 |
Concord Biotech Limited Appoints Raviraj Karia as Chief Financial Officer, Effective December 18, 2025
|
CI
| |
18/12 |
Concord Biotech Limited Appoints Raviraj Karia as Key Managerial Personnel, Effective December 18, 2025
|
CI
| |
08/12 |
Concord Biotech says CFO Lalit Sethi to retire
|
RE
| |
08/12 |
Concord Biotech's CFO Resigns; Shares Down 3%
|
MT
| |
08/12 |
Concord Biotech Limited Announces Retirement of Lalit Sethi as Chief Financial Officer, Effective January 5, 2026
|
CI
| |
08/12 |
Concord Biotech Limited Announces Retirement of Lalit Sethi as Key Managerial Personnel, Effective January 5, 2026
|
CI
| |
17/11 |
Jefferies Adjusts Concord Biotech's Price Target to INR1,500 From INR1,600, Keeps at Hold
|
MT
| |
14/11 |
Concord Biotech Limited, Q2 2026 Earnings Call, Nov 14, 2025
| | |
13/11 |
Concord Biotech posts Sept-quarter consol net profit 635.8 million rupees
|
RE
| |
13/11 |
Concord Biotech - approves acquisition of 100% equity in Celliimune Biotech
|
RE
| |
13/11 |
Concord Biotech Limited Approvesl to Invest Upto INR 100 Million in Captive Hybrid Solar Power Project for Limbasi Plant
|
CI
| |
13/11 |
Concord Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
|
CI
| |
13/11 |
Concord Biotech Limited agreed to acquire Celliimune Biotech Private Limited.
|
CI
| |
08/25/08 |
Indian Regulator Completes Inspection of Concord Biotech's Gujarat, India Unit
|
MT
| |
30/25/30 |
IIFL Starts Concord Biotech at Buy With INR1,970 Price Target
|
MT
| |
21/25/21 |
EU-GMP Authorities Conclude Inspection of Concord Biotech's Unit in Limbassi, India; Shares Up 3%
|
MT
| |
21/25/21 |
Concord Biotech says EU-GMP conducts first inspection of API facility
|
RE
| |
12/25/12 |
Jefferies Adjusts Concord Biotech's Price Target to INR1,600 From INR1,700, Keeps at Hold
|
MT
| |
11/25/11 |
Concord Biotech Limited, Q1 2026 Earnings Call, Aug 11, 2025
| | |
09/25/09 |
Concord Biotech Limited announces Annual dividend, payable on October 09, 2025
|
CI
| |
08/25/08 |
Concord Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
|
CI
| |
22/25/22 |
Concord Biotech Limited Announces Incorporation of Concord Lifegen Limited as Wholly Owned Subsidiary Company
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
